Liang-Piu Koh

5PUBLICATIONS
40CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)HaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 21, 2026
A Phase I/II Trial of Anti-CD22/CD19 CAR-T Cell Therapy, CART2219.1, in Adult and Pediatric Relapsed/Refractory B-ALL.

|Oct 06, 2025
Upfront memory T cell add-back with haploidentical TCRαβ-depleted graft in adults with haematological malignancies: a nationwide, multicentre, single-arm, prospective study.

Liang-Piu Koh, Yeh Ching Linn, Yang Liang Boo

|Oct 19, 2022
An ex vivo platform to guide drug combination treatment in relapsed/refractory lymphoma.

Jasmine Goh, Sanjay De Mel, Michal M Hoppe

|Jun 12, 2020
Phase I Trial of Expanded, Activated Autologous NK-cell Infusions with Trastuzumab in Patients with HER2-positive Cancers.

Soo-Chin Lee, Noriko Shimasaki, Joline S J Lim

Pageof 1

Frequent Collaborators

3 joint publications

Yeh Ching Linn

2 joint publications

Aloysius Yl Ho

2 joint publications

William Yk Hwang

2 joint publications

Jason Yongsheng Chan